HR Execs on the Move

Federation of American Hospitals

www.fah.org

 
The Federation of American Hospitals (FAH), founded in 1966, is the national representative of investor-owned or managed community hospitals and health systems throughout the United States and one of Washington, DC`s most respected and influential health policy and advocacy organizations. Dedicated to a market-based philosophy, we provide representation and advocacy on behalf of our members to Congress, the Executive Branch, the judiciary, media, academia, accrediting organizations and the public. The Federation of American Hospitals serves its members as a clearinghouse for information about the nation`s most vital health policy issues. These include Medicare and Medicaid, the uninsured, health care quality, ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.fah.org
  • 750 9th Street, North West. Suite 600
    Washington, DC USA 20001
  • Phone: 202.624.1527

Executives

Name Title Contact Details

Similar Companies

Baby and Company

At Baby+Company we want to change the world one birth at a time… We`re driven by a passion to expand women`s choices -to make what can feel like a choice between two extremes, hospital delivery and home birth, into a spectrum of options. Not because we don`t support these other models of care, but because for many women, neither feels like the right fit. So we`re building birth centers that celebrate the individuality of our families— through a model of care that brings together the centuries-old tradition of midwifery with the very best research, resources and data available today.

Master Train Inc

Master Train Inc is a San Antonio, TX-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Concordant Inc

Concordant Inc is a North Chelmsford, MA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

MedRepublic

We`ve created a global health marketplace where patients are empowered to make the healthcare choices that work for them.

Nkarta Therapeutics

Nkarta is a clinical-stage biotechnology company advancing the development of allogeneic natural killer (NK) cell therapies for cancer. By combining its cell expansion and cryopreservation platform with proprietary cell engineering technologies, Nkarta is building a pipeline of cell therapy candidates generated by efficient manufacturing processes, and engineered to enhance tumor targeting and improve persistence for sustained activity in the body.